Around the May 4-5 stress window, Morpho’s lending share rose while Aave V3’s TVL and borrowed value contracted sharply after the KelpDAO/rsETH event. That puts MORPHO back on the radar, but it also creates a harder investor question: is Morpho’s share gain only a short-term catalyst for the token, or can it become a longer-term support for MORPHO’s valuation?

The key question is not whether Morpho gained share during the Aave stress window; the data shows that it did. The harder question is whether that rotation reflects durable borrower and lender preference, or a temporary defensive move after a collateral-specific shock. CoinEx Research will examine this through market-share data, lending-design tradeoffs, and MORPHO’s revenue-to-tokenomics link.

Morpho’s Share Gain Is the Real Test

Morpho’s recent market-share gain matters because lending protocols are liquidity networks. Once deposits, borrowers, vault curators, and integrations begin to shift, the effect can compound.However, market share is only a useful signal if it persists after the initial stress event fades.

From February 4 to May 5, Aave V3’s share of the selected top lending set fell from about 59.7% to 41.5%, while Morpho Blue rose from about 12.6% to 21.2%. Over the same window, Aave V3 TVL fell from roughly $28.3B to $14.8B and borrowed value fell from about $21.0B to $12.1B. Morpho’s TVL held near $7.6B by May 5, while borrowed value remained near $4.0B. This supports the rotation narrative due to the KelpDAO/rsETH event , but it does not by itself prove that Morpho has permanently reset the lending market structure.

Morpho’s share gain came as Aave V3’s TVL and borrowed value contracted, but this is rotation evidence rather than proof of permanent migration.

The constructive read is that Morpho benefited from a moment when users became more sensitive to collateral-specific risk and protocol design. The cautious read is that Aave remains deeply integrated, highly liquid, and battle-tested. If Aave stabilizes and recovers deposits, Morpho’s share gain may look more like a stress-period rotation than a structural break.

Aave and Morpho Price Risk Differently

Aave V3 and Morpho Blue are both lending protocols, but they do not price or contain risk in the same way. Aave V3 emphasizes pooled liquidity, governance-managed risk controls, and broad integration across DeFi. Morpho Blue emphasizes isolated markets, permissionless market creation, immutable base-layer logic, and vault-level allocation through MetaMorpho.

Dimension	Aave V3	Morpho Blue
Liquidity model	Shared pooled liquidity across large markets	Isolated markets with vault-level routing
Risk control	Governance-defined parameters, caps, isolation mode, e-mode	Market-specific LLTV, oracle, collateral and loan asset choices
Strength	Deep liquidity, integrations, brand trust, crisis coordination	Modularity, permissionless markets, clearer market-level isolation
Stress path	Shared collateral stress can affect large pooled markets	Affected markets or vaults can face concentrated losses
Main tradeoff	More network effects, but broader contagion paths	More isolation, but more curator, oracle and fragmentation risk

The collateral charts make the mechanism difference more concrete. Before the event, Aave V3’s supplied-asset exposure was heavily concentrated in ETH/LST/LRT and BTC wrappers, with rsETH-related exposure visible at roughly $1.5B. By May 5, Aave’s total exposure proxy had contracted sharply, while ETH/LST/LRT still represented more than half of the remaining mix. Morpho’s vault/market exposure was smaller in absolute terms and more BTC-wrapper-heavy, especially around cbBTC, but this does not mean Morpho is risk-free. It means the failure mode is different: Aave’s pooled liquidity can spread collateral stress across a larger shared system, while Morpho’s isolated markets can contain blast radius but concentrate losses inside affected markets or vaults.

This is why the comparison should not be reduced to “Morpho safe, Aave risky.” Aave’s shared-liquidity model is also the reason it has historically attracted the deepest borrower demand and the strongest integrations. Morpho’s isolated design may reduce some system-wide contagion paths, but vault users still depend on curator choices, oracle quality, collateral liquidity, and the risk parameters of each underlying market.

Future LST, LRT, bridge, redemption, or oracle stress could still hit Aave if a large collateral asset enters shared markets and later breaks assumptions. A similar event on Morpho would likely be more localized by market or vault, but users in those markets could still face severe losses. We conclude that the difference is not the absence of risk; it is how risk is distributed.

Can MORPHO Capture the Upside?

For MORPHO, the token question is separate from the protocol-share question. TVL and borrow growth can improve the narrative, attract integrations, and increase the perceived value of future fee optionality. However, protocol usage does not automatically create direct token value accrual.

The token chart argues for caution. Morpho’s TVL rose materially over the broader 2025-2026 window, but MORPHO’s FDV, market cap, and fee trend did not move in a clean one-to-one relationship with protocol usage. Fees improved during parts of the cycle, yet the token’s value capture remains indirect. Today, MORPHO is primarily a governance asset; the market can price future fee optionality, but current protocol usage should not be treated as automatic token cash flow.

MORPHO’s FDV and market cap do not move one-for-one with TVL or fees, reinforcing that usage growth is not yet direct token value accrual.

This makes MORPHO a governance-and-optionality thesis rather than a straightforward fee-cash-flow thesis today. If governance later defines a credible path for protocol revenue, a fee switch, or another value-capture mechanism, the market may reassess the token’s relationship to protocol fundamentals. Until then, investors should separate three layers: Morpho’s protocol adoption, Morpho’s fee generation, and MORPHO’s direct token accrual.

What Would Confirm the MORPHO Thesis

The stronger confirmation would be a persistent gap between Morpho’s share and Aave’s recovery, not only a short-lived post-event rotation. Investors should also watch whether Morpho’s vault growth remains concentrated in high-quality collateral rather than chasing risky yield, whether fees rise alongside TVL without excessive incentives, and whether governance creates a credible path from protocol revenue to token value accrual.

Four signals would make the thesis stronger:

Morpho share remains elevated after Aave V3 stabilizes.
High-quality vaults gain deposits without relying on aggressive risk-taking.
Fees rise with usage, rather than only TVL moving higher.
Governance clarifies whether and how protocol revenue can connect to MORPHO.

Until those signals appear together, Morpho’s share gain should be treated as a meaningful development, but not yet as conclusive evidence of durable token support.

Disclaimer: This content is for reference only and does not constitute investment advice. Information may be incomplete or inaccurate. Please do your own research; the author assumes no responsibility for losses.

MORPHO Analysis: Is Morpho’s Lending Share Gain a Short-Term Catalyst or Long-Term Support?